Raymond James Financial
WST icon

Raymond James Financial’s West Pharmaceutical WST Stock Holding History

Raymond James Financial’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.1M Buy
92,072
+9,513
+12% +$2.91M 0.01% 1206
2026
Q1 		$20.7M Sell
82,559
-19,889
-19% -$4.95M 0.01% 1448
2025
Q4 		$28.2M Sell
102,448
-18,002
-15% -$4.92M 0.01% 1207
2025
Q3 		$31.6M Sell
120,450
-6,221
-5% -$1.51M 0.01% 1104
2025
Q2 		$27.7M Sell
126,671
-106,796
-46% -$22.8M 0.01% 1133
2025
Q1 		$52.3M Buy
233,467
+11,685
+5% +$3.22M 0.02% 699
2024
Q4 		$72.6M Buy
+221,782
New +$69.8M 0.03% 542

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Raymond James Financial's WST Position: Q2 2026 in Review

Raymond James Financial increased its West Pharmaceutical (WST) stake by 12% in Q2 2026, buying an estimated $2.91M and bringing the position to 92,072 shares worth $33.1M. The position accounts for 0.01% of the portfolio, ranked #1206.

Raymond James Financial first reported a position in WST in Q4 2024 and has held it in 7 quarters since. The position peaked at $72.6M in Q4 2024. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Raymond James Financial held 92,072 shares of West Pharmaceutical worth $33.1M as of Q2 2026.
  • Raymond James Financial bought 9,513 West Pharmaceutical shares in Q2 2026, an estimated $2.91M.
  • West Pharmaceutical made up 0.01% of Raymond James Financial's portfolio in Q2 2026, its #1206 holding.
  • Raymond James Financial first reported a position in West Pharmaceutical in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's West Pharmaceutical position peaked at $72.6M in Q4 2024.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.